Monitoring of airway resistance (Raw) in exacerbation of asthma

T. Jalusic Gluncic, L. Basara Toromanovic (Zagreb, Croatia)

Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Session: Monitoring lung function in airway diseases
Session type: Thematic Poster Session
Number: 788
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Jalusic Gluncic, L. Basara Toromanovic (Zagreb, Croatia). Monitoring of airway resistance (Raw) in exacerbation of asthma. Eur Respir J 2013; 42: Suppl. 57, 788

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Atomization inhalation on the NO content in the airway of patients with bronchial asthma
Source: International Congress 2016 – The wide spectrum of respiratory nursing research and practice: across all ages and diseases
Year: 2016

Discordance between asthma control parameters in patients with frequent vs infrequent asthma exacerbations
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014

Factors associated with uncontrolled asthma in patients with aspirin-exacerbated respiratory disease (AERD)
Source: International Congress 2014 – Asthma: still a heterogeneous condition!
Year: 2014


The usefulness of FeNO and the mannitol test in detecting airway eosinophilia in asthma patients with uncontrolled symptoms
Source: International Congress 2014 – Biomarkers of asthma control
Year: 2014


Efficacy of carbamazepine in treatment of bronchial asthma
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013


Codeine for treatment of cough variant asthma
Source: International Congress 2016 – Asthma points to ponder
Year: 2016

Predictors of exacerbations in asthma
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015


Long-term FEV1 decline and airway hyperresponsiveness in asthma
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014

Improved effects of formoterol-budesonide combination on residual eosinophilic inflammation in asthmatic peripheral airway
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013


Effect of oral corticosteroids on symptomatic reflux in severe allergic asthma: Is there a link?
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014


Characterisation of asthma patients with persistent airflow obstruction
Source: International Congress 2016 – Clinical studies in asthma and immunology
Year: 2016


Predictors of good inhaler technique in asthma and COPD
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015


Using induced sputum cell counts to guide management of difficult-to-treat asthmatics
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013


Importance of inhalation device in asthma and COPD: A consensus using Delphi
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013


Pharmacogenetics in severity of bronchial hyperresponsiveness in asthma
Source: Annual Congress 2013 –Genetic factors in airway development and disease
Year: 2013

Small airways obstruction and asthma exacerbations
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014

Improvement in asthma control and airway inflammation during a period of electronic monitoring
Source: International Congress 2015 – Paediatric asthma and allergy: e-health in management
Year: 2015


Changes in symptoms, respiratory function, airway inflammation, and airway hyperresponsiveness over 10 year of inhaled corticosteroid therapy in adult asthma patients
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015


Air trapping in relation to airways inflammation and bronchial responsiveness in patients with respiratory symptoms suggestive of asthma
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014

Improved effects of aerosol-type fluticasone propionate/formoterol combination on residual asthmatic inflammation in distal airways of patients with moderate asthma
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014